Ensign Peak Advisors, Inc
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$931,331
+$289,655 QoQ
Shares Held
93,979
-10.2% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. DNA ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in DNA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $931,331 | 93,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $641,676 | 104,678 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,744,984 | 330,323 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,885,364 | 335,073 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,722,748 | 330,911 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,860,542 | 326,411 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,205,650 | 326,441 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,660,494 | 326,441 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 DNABW | — | 16,100 | Shares | Sole | 2024-08-13 | |
| 2024-06-30 | $620,452 | 1,857,641 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 DNABW | — | 16,100 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $2,156,474 | 1,859,030 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 DNABW | — | 16,100 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $3,278,880 | 1,940,166 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 DNABW | — | 16,100 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $1,988,127 | 1,098,413 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 DNABW | — | 16,100 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $2,046,407 | 1,100,219 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 DNABW | — | 16,100 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $4,579,760 | 3,443,429 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 DNABW | — | 16,100 | Shares | Sole | 2023-02-13 | |
| 2022-12-31 | $5,824,436 | 3,446,412 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 DNABW | — | 16,100 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $11,670,394 | 3,740,511 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 DNABW | — | 16,100 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $8,902,415 | 3,740,511 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 DNABW | — | 16,100 | Shares | Sole | 2022-05-16 | |
| 2022-03-31 | $13,889,040 | 3,446,412 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 DNABW | — | 16,100 | Shares | Sole | 2022-02-11 | |
| 2021-12-31 | $31,083,646 | 3,740,511 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 DNABW | — | 16,100 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $933,018 | 80,502 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||